PIK3CA c.3153G>T ;(p.W1051C)

Variant ID: 3-178952098-G-T

NM_006218.2(PIK3CA):c.3153G>T;(p.W1051C)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Identification of Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.

Frontiers In Immunology
Li, Na N; Wang, Jiahong J; Zhan, Xianquan X
Publication Date: 2021

Variant appearance in text: PIK3CA: 3153G>T; W1051C
PubMed Link: 34887858
Variant Present in the following documents:
  • Table_3.xlsx, sheet 1
View BVdb publication page



A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamics of Combination Therapy with Refametinib plus Sorafenib in Patients with Advanced Cancer.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Adjei, Alex A AA; Richards, Donald A DA; El-Khoueiry, Anthony A; Braiteh, Fadi F; Becerra, Carlos H R CH; Stephenson, Joe J JJ; Hezel, Aram F AF; Sherman, Morris M; Garbo, Lawrence L; Leffingwell, Diane P DP; Iverson, Cory C; Miner, Jeffrey N JN; Shen, Zancong Z; Yeh, Li-Tain LT; Gunawan, Sonny S; Wilson, David M DM; Manhard, Kimberly J KJ; Rajagopalan, Prabhu P; Krissel, Heiko H; Clendeninn, Neil J NJ
Publication Date: 2016-05-15

Variant appearance in text: PIK3CA: W1051C
PubMed Link: 26644411
Variant Present in the following documents:
  • Main text
View BVdb publication page